KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Liabilities (2016 - 2025)

Charles River Laboratories International has reported Total Liabilities over the past 17 years, most recently at $3.9 billion for Q4 2025.

  • For Q4 2025, Total Liabilities fell 2.39% year-over-year to $3.9 billion; the TTM value through Dec 2025 reached $3.9 billion, down 2.39%, while the annual FY2025 figure was $3.9 billion, 2.39% down from the prior year.
  • Total Liabilities for Q4 2025 was $3.9 billion at Charles River Laboratories International, down from $4.1 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $4.8 billion in Q2 2022 and troughed at $3.6 billion in Q1 2021.
  • A 5-year average of $4.3 billion and a median of $4.4 billion in 2021 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: soared 341.59% in 2021 and later decreased 11.37% in 2024.
  • Year by year, Total Liabilities stood at $4.4 billion in 2021, then rose by 3.32% to $4.6 billion in 2022, then decreased by 0.94% to $4.5 billion in 2023, then fell by 11.37% to $4.0 billion in 2024, then fell by 2.39% to $3.9 billion in 2025.
  • Business Quant data shows Total Liabilities for CRL at $3.9 billion in Q4 2025, $4.1 billion in Q3 2025, and $4.2 billion in Q2 2025.